4Lin MS, Dai YS, Pwu RF, et al. Risk estimates for drugs suspectedof being associated with Stevens-Johnson syndrome and toxic epider-mal necrolysis : a case-control study [ J ]. Intern Med J,2005,35(3) :188-190.
5Thong BY, Tan TC. Epidemiology and risk factors for drug allergy[J].Br J Clin Pharmacol, 2011,71(5) :684-700.
6Roujeau JC. Treatment of severe drugeruptions [ J ]. JDermatol1999,26(11) :718-722.
7Shiohara T,Inaoka M, Kano Y. Drug-induced hypersensitivity syn-drome (DIHS) : a reaction induced by a complex interplay amongherpesvirusesand antiviral and antidrug immune responses [ J ].Allergol Int, 2006,55(1):1-8.
8Imbach P, Lazarus AH, Ktihne T. Intravenous immunoglobulins in-duce potentially synergistic immunoraodulations in autoimmune dis-orders[J]. Vox Sang, 2010,98(3 Pt2) :385-394.
9Fernandez AP, Kerdel FA. The use of i. v. IG therapy in dermatol-ogy[J]. Dermatol Ther,2007,20(4) :288-305.
